mRNA and protein expression were investigated in 48 tissue specimens from neuroblastoma patients, and low NDRG1 expression was significantly associated with prognostic factors such as primary tumor size, MYCN amplification, and poor prognosis [70]. This evidence concerns the gene NDRG1 and neoplasm.